| Kathleen D Harding-steinsberger, CNM | |
|
5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235-7708 | |
| (214) 590-5306 | |
| (214) 590-2798 |
| Full Name | Kathleen D Harding-steinsberger |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 5201 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427114826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 601079 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen D Harding-steinsberger, CNM Po Box 660599, Dallas, TX 75266-0599 Ph: (214) 590-4105 | Kathleen D Harding-steinsberger, CNM 5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235-7708 Ph: (214) 590-5306 |
News Archive
Saint Mark's Cathedral on Capitol Hill will host the Seattle AIDS Memorial on Saturday, September 24, 2011, at 7:00 p.m. Subtitled "30 Years of Sorrow, Comfort and Hope," the memorial commemorates the 30th anniversary of the first HIV/AIDS diagnosis as well as the 25th anniversary of the first AIDS Walk in Seattle.
Japanese researchers have discovered a good reason for women to drink coffee - they say it protects them from cancer of the uterus.
S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.
Janssen Biotech, Inc., one of the Janssen pharmaceutical companies of Johnson & Johnson announced today an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, an immuno-oncology agent currently in Phase 1 clinical studies.
"This week, PATH and our partners celebrated the official launch of the production line for a new synthetic version of artemisinin, the key ingredient for the gold-standard malaria treatment - one that plays a major role in protecting the lives of children and adults worldwide," PATH President and CEO Steve Davis writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
Ms. Valerie Joy Phillips, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3453 Saint Francis Ave, Suite 128, Dallas, TX 75228 Phone: 972-279-0559 | |
Jessica Frankfurt, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 8305 Walnut Hill Ln Ste 100, Dallas, TX 75231 Phone: 214-363-7801 | |
Waltona Cummings, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235 Phone: 214-590-5306 Fax: 214-590-2798 | |
Susan P Hovinen, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-3838 Fax: 214-645-0078 | |
Sherry Ann Burnam, C.N.M. Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5750 Pineland Dr Ste 300a, Dallas, TX 75231 Phone: 214-221-0855 Fax: 239-343-7185 | |
Phyllis Nzeakor, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000 | |
Shannon G. Curtis, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235 Phone: 214-590-5306 Fax: 214-590-2798 |